Amgen leases 500,000 sq ft in Hyderabad to establish its first global capability centre, enhancing its office space in the ...

Hyderabad: BioAsia 2025, the 22nd edition of what is touted as one of the largest gatherings of experts and global honchos ...

That could differentiate it from Amgen and AstraZeneca's Tezspire (tezepelumab ... and Hevolution Foundation. Hyderabad, India-based contract development and manufacturing organisation (CDMO ...

Amgen (AMGN) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.

Biotechnology specialist Amgen (NASDAQ:AMGN) reported fourth-quarter and full-year 2024 earnings on Tuesday, Feb. 4, that topped analysts' consensus estimates. Analysts estimated Q4 adjusted EPS ...

RBC Capital analyst Gregory Renza maintained a Buy rating on Amgen (AMGN – Research Report) yesterday and set a price target of $320.00. The company’s shares closed yesterday at $289.02.